Cargando…

Dabigatran Added to Dual Antiplatelet Therapy to Treat a Left Ventricular Thrombus in an 87 Year Old Patient With Myocardial Infarction and Very High Bleeding Risk

Background: A left ventricular (LV) thrombus is detected in approximately 5–10% of patients after myocardial infarction (MI). If left untreated, these LV thrombi carry a significant risk of complications including embolic stroke. According to current guidelines, anticoagulation with vitamin K antago...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noflatscher, Maria, Moes, Nicolas, Gassner, Eva-Maria, Marschang, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893831/ https://www.ncbi.nlm.nih.gov/pubmed/29670522 http://dx.doi.org/10.3389/fphar.2018.00217

Ejemplares similares

Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy
por: Solheim, Svein, et al.
Publicado: (2013)

Dabigatran for left atrial thrombus
por: Morita, Sae, et al.
Publicado: (2013)

Bleeding risk with dabigatran, rivaroxaban, warfarin, and antiplatelet agent in Asians with non-valvular atrial fibrillation
por: Chan, Yi-Hsin, et al.
Publicado: (2017)

Dabigatran Effect on Left Ventricular Thrombus in a Patient with Acute Ischemic Stroke
por: Chung, Kyuyoon, et al.
Publicado: (2015)

Large Left Ventricular Thrombus as a Cause of Recurrent Cardioembolic Stroke While on Dabigatran
por: Moey, Melissa Y.Y., et al.
Publicado: (2018)

Use of dabigatran for treatment of left ventricular thrombus: A tertiary care center experience
por: Verma, Bhupendra, et al.
Publicado: (2019)

Dual antiplatelet agents and Rivaroxaban for massive intracoronary thrombus in STEMI
por: Jamal, Nasiruddin, et al.
Publicado: (2015)

Thrombus Formation in Left Atrium on Dabigatran Therapy
por: Shah, Priyank, et al.
Publicado: (2015)

Dual Antiplatelet Therapy and the Severity Risk of Lower Intestinal Bleeding
por: Carlin, Neal, et al.
Publicado: (2017)

The Dipyridamole Added to Dual Antiplatelet Therapy in Cerebral Infarction After First Acute Myocardial Infarction: A Nationwide, Case-Control Study
por: Wang, Mei-Tzu, et al.
Publicado: (2018)

Management of dabigatran-induced bleeding: expert statement
por: Fries, Dietmar, et al.
Publicado: (2013)

Patient perspectives of nuisance bleeding and adherence to dual antiplatelet therapy: a qualitative study
por: Pithara, Christalla, et al.
Publicado: (2020)

Dabigatran Plasma Measurement to Guide the Management of Acute Bleeding and Thrombotic Complications
por: Tala, Maurizio, et al.
Publicado: (2018)

Features of Cerebral Infarction Due to Left Ventricular Thrombus
por: Terasawa, Yuka, et al.
Publicado: (2022)

Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation
por: Staudacher, Dawid L., et al.
Publicado: (2016)

Very late bioresorbable scaffold thrombosis after discontinuation of dual antiplatelet therapy
por: Karanasos, Antonios, et al.
Publicado: (2014)

Clinical Evaluation of Role of Dual Antiplatelet Therapy on Bleeding after Dental Extraction
por: Babaji, Prashant, et al.
Publicado: (2018)

Risk of bleeding in patients with continued dual antiplatelet therapy during orthopedic surgery
por: Hu, San-Bao, et al.
Publicado: (2019)

Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease
por: Tung, Ying-Chang, et al.
Publicado: (2020)

Resolution of a warfarin and dabigatran-resistant left atrial appendage thrombus with apixaban
por: Miwa, Yosuke, et al.
Publicado: (2016)

Myotonic dystrophy type 1 and pulmonary embolism: successful thrombus resolution with dabigatran etexilate therapy
por: GALLINORO, EMANUELE, et al.
Publicado: (2018)

NGAL Correlates with Femoral and Carotid Plaque Volume Assessed by Sonographic 3D Plaque Volumetry
por: Schreinlechner, Michael, et al.
Publicado: (2020)

Dabigatran and myocardial infarction: a foggy scenario
por: Pontillo, Daniele, et al.
Publicado: (2014)

Left ventricular thrombus formation after acute myocardial infarction
por: Delewi, Ronak, et al.
Publicado: (2012)

BF066, a Novel Dual Target Antiplatelet Agent without Significant Bleeding
por: Pan, ChangE, et al.
Publicado: (2012)

Left atrial appendage thrombus on full-dose dabigatran treatment: a case report
por: Candelaresi, Paolo, et al.
Publicado: (2020)

The impact of dual antiplatelet therapy administration on the risk of bleeding complications during coronary artery bypass surgery
por: Nardi, Paolo, et al.
Publicado: (2021)

87-year-old woman with improved pulmonary function following accidental long-term inhalation therapy with dabigatran
por: Pönitz, Volker, et al.
Publicado: (2018)

Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors
por: Pasea, Laura, et al.
Publicado: (2017)

Use of a specific antidote to dabigatran (idarucizumab) reduces blood loss and mortality in dabigatran-induced and trauma-induced bleeding in pigs
por: Honickel, M, et al.
Publicado: (2014)

Influence of Traditional Cardiovascular Risk Factors on Carotid and Femoral Atherosclerotic Plaque Volume as Measured by Three-Dimensional Ultrasound
por: Noflatscher, Maria, et al.
Publicado: (2018)

Association of Food and Alcohol Consumption with Peripheral Atherosclerotic Plaque Volume as Measured by 3D-Ultrasound
por: Noflatscher, Maria, et al.
Publicado: (2020)

High baseline fetuin-A levels are associated with lower atherosclerotic plaque progression as measured by 3D ultrasound
por: Sommer, Philip, et al.
Publicado: (2021)

Increasing Soluble P-Selectin Levels Predict Higher Peripheral Atherosclerotic Plaque Progression
por: Sommer, Philip, et al.
Publicado: (2023)

Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban
por: Charlton, Blake, et al.
Publicado: (2018)

Dabigatran: Clinical correlation of drug and its dose with risk of stroke and bleeding
por: Shaji, Anitta, et al.
Publicado: (2023)

Single and dual antiplatelet therapy in elderly patients of medically managed myocardial infarction
por: Lin, Ting-Tse, et al.
Publicado: (2018)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
por: Laredo, Viviana, et al.
Publicado: (2020)

Dual Antiplatelet Therapy and Cancer; Balancing between Ischemic and Bleeding Risk: A Narrative Review
por: Tsigkas, Grigorios, et al.
Publicado: (2023)

Recurrent Non-Variceal Upper Gastrointestinal Bleeding among Patients Receiving Dual Antiplatelet Therapy
por: Yoo, Ah Young, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ob03qtdcr353qmji1t8v2vsaa7